ReShape Lifesciences (RSLS) Short Interest Ratio & Short Volume

Short interest is the volume of ReShape Lifesciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 72,900 shares of RSLS short. Learn More on ReShape Lifesciences' current short interest.

ReShape Lifesciences saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 72,900 shares, a drop of 93.0% from the previous total of 1,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to ReShape Lifesciences: Abbott Laboratories (1.22%), Intuitive Surgical, Inc. (1.29%), Boston Scientific Co. (1.06%), Stryker Co. (1.60%), Medtronic plc (0.96%), Becton, Dickinson and Company (1.27%), Edwards Lifesciences Co. (1.43%), IDEXX Laboratories, Inc. (3.61%), ResMed Inc. (6.43%), DexCom, Inc. (2.91%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

Short selling RSLS is an investing strategy that aims to generate trading profit from ReShape Lifesciences as its price is falling. RSLS shares are trading down $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for ReShape Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RSLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSLS, twice per month. The most recent reporting period available is April, 30 2025.